ArticleCancer medicine2024
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.
Adam Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it